Literature DB >> 17973969

Prospective age-matching in elderly kidney transplant recipients--a 5-year analysis of the Eurotransplant Senior Program.

U Frei1, J Noeldeke, V Machold-Fabrizii, H Arbogast, R Margreiter, L Fricke, A Voiculescu, V Kliem, H Ebel, U Albert, K Lopau, P Schnuelle, B Nonnast-Daniel, F Pietruck, R Offermann, G Persijn, C Bernasconi.   

Abstract

Renal transplantation faces challenges: the organ shortage resulting in extended waiting times and an aging population resulting in death with a functioning graft. The Eurotransplant Senior Program (ESP) allocates kidneys within a narrow geographic area from donors aged >/=65 years to recipients >/=65 years regardless of HLA. This analysis investigates the impact of the ESP on waiting time, graft and patient survival. The ESP group (n = 1406, old to old) was compared to two groups allocated via the Eurotransplant Kidney Allocation System (ETKAS) with either similar donor age (old to any [O/A], donor age >/=65, n = 446) or recipient age (any to old, [A/O], recipient age 60-64, n = 1687). All patients were transplanted between 1999 and 2004. Since initiation of the ESP (1999), availability of elderly donors doubled and waiting time for ESP patients decreased. Local allocation led to shorter cold ischemia time (11.9 vs. >17.0 h, p < 0.001) and less delayed graft function (DGF, ESP 29.7% vs. O/A 36.2%, p = 0.047) but 5-10% higher rejection rates. Graft and patient survival were not negatively affected by the ESP allocation when compared to the standard allocation. The ESP age matching of elderly donors and recipients is an effective allocation system for organs from elderly donors.

Entities:  

Mesh:

Year:  2007        PMID: 17973969     DOI: 10.1111/j.1600-6143.2007.02014.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  72 in total

1.  Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States.

Authors:  Jagbir Gill; Marcelo Sampaio; John S Gill; James Dong; Hung-Tien Kuo; Gabriel M Danovitch; Suphamai Bunnapradist
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

2.  How immunosuppressive therapy affects T cells from kidney transplanted patients of different age: the role of latent cytomegalovirus infection.

Authors:  K Welzl; B Weinberger; A Kronbichler; G Sturm; G Kern; G Mayer; B Grubeck-Loebenstein; C Koppelstaetter
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

3.  The scenario of delayed graft function in Brazil.

Authors:  Tainá Veras de Sandes-Freitas
Journal:  J Bras Nefrol       Date:  2019-02-25

4.  Pathology: donor biopsy evaluation at time of renal grafting.

Authors:  Volker Nickeleit
Journal:  Nat Rev Nephrol       Date:  2009-05       Impact factor: 28.314

Review 5.  Kidney donation after cardiac death.

Authors:  Jacob A Akoh
Journal:  World J Nephrol       Date:  2012-06-06

6.  Outcomes of transplanting deceased-donor kidneys between elderly donors and recipients.

Authors:  Markus Giessing; T Florian Fuller; Frank Friedersdorff; Serdar Deger; Andreas Wille; Hans-Hellmut Neumayer; Danilo Schmidt; Klemens Budde; Lutz Liefeldt
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

Review 7.  Kidney transplantation in the elderly.

Authors:  Edmund Huang; Dorry L Segev; Hamid Rabb
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

8.  Age-Dependent Metabolic and Immunosuppressive Effects of Tacrolimus.

Authors:  F Krenzien; M Quante; T Heinbokel; M Seyda; K Minami; H Uehara; H R C Biefer; J M Schuitenmaker; S Gabardi; K Splith; M Schmelzle; A K Petrides; H Azuma; J Pratschke; X C Li; A ElKhal; S G Tullius
Journal:  Am J Transplant       Date:  2016-11-21       Impact factor: 8.086

9.  [Ten years of the Eurotransplant senior program : are there still age limits for kidney transplantation?].

Authors:  M Giessing
Journal:  Urologe A       Date:  2009-12       Impact factor: 0.639

10.  Cytomegalovirus disease in African-American kidney transplant patients.

Authors:  J McGee; V Mave; C L Yau; M Killackey; A Paramesh; J Buell; D P Slakey; L L Hamm; R Zhang
Journal:  Transpl Infect Dis       Date:  2012-12       Impact factor: 2.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.